Funder: National Institutes of Health

Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.

Summary: Supports mechanistic clinical research on how expectancy effects influence cancer symptom management, with emphasis on diverse and underserved populations.

Key Information: Clinical trial required; applications must use an experimental medicine approach and cannot use deceptive placebo conditions.